SCHEMBL7304716

SCHEMBL7304716

O=C(N[C@@H](Cn1cccn1)C(=O)N[C@@H](Cc1ccccc1)[C@@H]1O[C@@H]1[C@H](Cc1ccccc1)NC(=O)[C@H](Cn1cccn1)NC(=O)OCc1ccccc1)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CTSL P07711 5/20 0.45
CTSB P07858 3/20 0.45
CTSS P25774 3/20 0.45
SCN9A Q15858 1/20 0.45
TACR1 P25103 2/20 0.44
CYP3A4 P08684 1/20 0.44
CTSK P43235 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7298448 0.83 CTSK (0.56) CTSLCTSBCTSSTACR1CTSK
SCHEMBL305819 0.81 CASP1 (0.48) CTSLCTSBCTSSTACR1CTSK
SCHEMBL305818 0.81 CASP1 (0.48) CTSLCTSBCTSSTACR1CTSK
SCHEMBL7295499 0.79 CTSL (0.51) CTSLCTSBCTSSTACR1CTSK
SCHEMBL4945460 0.79 CTRB1 (0.58) CTSLCTSBCTSSTACR1CTSK
SCHEMBL7306251 0.78 CTSL (0.59) CTSLCTSBCTSSTACR1CTSK
SCHEMBL7298678 0.77 MME (0.53) CTSLCTSBCTSSTACR1CTSK
SCHEMBL7305584 0.76 CYP1A2 (0.53) CTSLCTSBCTSSTACR1CTSK
SCHEMBL7309667 0.76 CTSL (0.48) CTSLCTSBCTSSTACR1CTSK
SCHEMBL14879202 0.75 ATM (0.51) CTSLCTSBCTSSCYP3A4CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed